Cellectar Biosciences, Inc. (CLRB) vs Passage Bio, Inc. (PASG)
A side-by-side comparison of Cellectar Biosciences, Inc. and Passage Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLRB
Cellectar Biosciences, Inc.
$1.62HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
PASG
Passage Bio, Inc.
$4.03HealthcareDelayed quote: Oct 6, 2026, 1:33 PM EDT
Total return — CLRB vs PASG
growth of $100 · dividends reinvested · last 7yCLRB -99.6% (-55.3%/yr)PASG -99.1% (-48.8%/yr)PASG compounded faster over this window
CLRB PASG
CLRB vs PASG: by the numbers
- •PASG is the larger company ($13M vs $13M market cap).
Metrics side by side
Valuation
| Metric | CLRB | PASG |
|---|---|---|
| P/B ratio | 0.43 | 2.91 |
Profitability
| Metric | CLRB | PASG |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -74.73% | -810.41% |
| ROIC | -74.94% | -889.92% |
Growth (annualized)
| Metric | CLRB | PASG |
|---|---|---|
| Total return CAGR (5Y) | -60.51% | -53.23% |
Frequently asked
- How have CLRB and PASG total returns compared?
- Over the past 5 years, CLRB delivered -60.51% and PASG delivered -53.23% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.